PMID- 20058479
OWN - NLM
STAT- MEDLINE
DCOM- 20100511
LR  - 20191111
IS  - 1658-3876 (Print)
IS  - 2589-0646 (Linking)
VI  - 1
IP  - 4
DP  - 2008 Oct-Dec
TI  - Hematopoietic stem cell transplantation in Iran: 1991 to 2008.
PG  - 231-8
AB  - Since 1991, 2042 first hematopoietic stem cell transplants (HSCT) have been 
      performed at the Hematology-Oncology and Stem Cell Transplantation Research 
      Center at Tehran University of Medical Sciences. Acute myelogenous leukemia (548 
      patients), thalassemia major (335 patients) and acute lymphoblastic leukemia (275 
      patients) have been the most common transplanted disorders. There were 1418 cases 
      that received allogeneic HSCT and 624 cases that have received autologous HSCT. 
      The numbers of allogeneic and autologous HSCT have increased, but the allogeneic 
      to autologous ratio has remained constant. The first peripheral blood 
      hematopoietic stem cell transplantation was performed in 1996; since then, 1671 
      have been done. The donor types for 1418 allogeneic first HSCT were 1367 (96.4%) 
      human leukocyte antigen (HLA) matched-identical siblings, 29 (2%) HLA-mismatched 
      sibling/other relative, 13 (0.9%) syngeneic twins, 5 (0.4%) HLA-matched other 
      relatives and 4 (0.3%) unrelated. The first cord blood hematopoietic stem cell 
      transplantation was performed in 1998 and since then there have been 14 patients 
      that have obtained cord blood transplantations. Recently, new methods have been 
      used like donor lymphocyte infusion (DLI) and cellular therapy. There were 111 
      patients with cellular therapy for post-myocardial infarction, cirrhosis, 
      thalassemia major, multiple sclerosis, head of femur necrosis and renal cell 
      carcinoma.
FAU - Ghavamzadeh, Ardeshir
AU  - Ghavamzadeh A
AD  - Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran 
      University of Medical Sciences, Dr. Shariati Hospital, Tehran, Iran.
FAU - Alimogaddam, Kamran
AU  - Alimogaddam K
FAU - Jahani, Mohammad
AU  - Jahani M
FAU - Mousavi, Seyedasadollah
AU  - Mousavi S
FAU - Iravani, Masoud
AU  - Iravani M
FAU - Bahar, Babak
AU  - Bahar B
FAU - Khodabandeh, Ali
AU  - Khodabandeh A
FAU - Khatami, Farnaz
AU  - Khatami F
FAU - Jalali, Arash
AU  - Jalali A
LA  - eng
PT  - Journal Article
PL  - Saudi Arabia
TA  - Hematol Oncol Stem Cell Ther
JT  - Hematology/oncology and stem cell therapy
JID - 101468532
SB  - IM
MH  - Hematologic Diseases/surgery
MH  - Hematopoietic Stem Cell Transplantation/*statistics & numerical data
MH  - Humans
MH  - Immune System Diseases/surgery
MH  - Iran
MH  - Neoplasms/surgery
EDAT- 2008/10/01 00:00
MHDA- 2010/05/12 06:00
CRDT- 2010/01/12 06:00
PHST- 2010/01/12 06:00 [entrez]
PHST- 2008/10/01 00:00 [pubmed]
PHST- 2010/05/12 06:00 [medline]
AID - S1658-3876(08)50010-0 [pii]
AID - 10.1016/s1658-3876(08)50010-0 [doi]
PST - ppublish
SO  - Hematol Oncol Stem Cell Ther. 2008 Oct-Dec;1(4):231-8. doi: 
      10.1016/s1658-3876(08)50010-0.